audit in pharma industry - An Overview
Processes must provide for evaluating the impurity profile of each reworked batch from batches manufactured with the proven procedure. Where by regime analytical approaches are insufficient to characterize the reworked batch, further techniques should be applied.This steering applies to the manufacture of APIs for use in human drug (medicinal) prod